Identification and clinical implications of recurrent PAX5::MLLT3 fusion in lymphoid blastic phase chronic myeloid leukemia

被引：0
|
作者：
Wang, Lijun [1 ]
Chen, Yu [2 ]
Wang, Qingyuan [1 ]
Xiang, Meng [1 ]
Zeng, Zhao [1 ]
Zhang, Zhibo [1 ]
Zhang, Fenghong [1 ]
Chen, Suning [1 ,3 ,4 ]
Xue, Mengxing [1 ,4 ]
机构：
[1] Soochow Univ, Jiangsu Inst Hematol, Natl Clin Res Ctr Hematol Dis, Affiliated Hosp 1, Suzhou, Peoples R China
[2] Wannan Med Coll, Dept Hematol, Affiliated Hosp 2, Wuhu, Peoples R China
[3] Soochow Univ, Inst Blood & Marrow Transplantat, Collaborat Innovat Ctr Hematol, Suzhou, Peoples R China
[4] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Suning Chen & Mengxing Xue, Shizi St 188, Suzhou 215006, Peoples R China
来源：
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY | 2024年 / 46卷 / 03期
基金：
中国国家自然科学基金;
关键词：
PAX5; TRANSFORMATION; GENE;
D O I：
10.1111/ijlh.14245
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：571 / 574
页数：4
相关论文
共 50 条
  • [21] PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study
    J Familiades
    M Bousquet
    M Lafage-Pochitaloff
    M-C Béné
    K Beldjord
    J De Vos
    N Dastugue
    E Coyaud
    S Struski
    C Quelen
    N Prade-Houdellier
    S Dobbelstein
    J-M Cayuela
    J Soulier
    N Grardel
    C Preudhomme
    H Cavé
    O Blanchet
    V Lhéritier
    A Delannoy
    Y Chalandon
    N Ifrah
    A Pigneux
    P Brousset
    E A Macintyre
    F Huguet
    H Dombret
    C Broccardo
    É Delabesse
    Leukemia, 2009, 23 : 1989 - 1998
  • [22] PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study
    Familiades, J.
    Bousquet, M.
    Lafage-Pochitaloff, M.
    Bene, M. -C
    Beldjord, K.
    De Vos, J.
    Dastugue, N.
    Coyaud, E.
    Struski, S.
    Quelen, C.
    Prade-Houdellier, N.
    Dobbelstein, S.
    Cayuela, J-M
    Soulier, J.
    Grardel, N.
    Preudhomme, C.
    Cave, H.
    Blanchet, O.
    Lheritier, V.
    Delannoy, A.
    Chalandon, Y.
    Ifrah, N.
    Pigneux, A.
    Brousset, P.
    Macintyre, E. A.
    Huguet, F.
    Dombret, H.
    Broccardo, C.
    Delabesse, E.
    LEUKEMIA, 2009, 23 (11) : 1989 - 1998
  • [23] A CASE OF MATURE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN A 5-YEAR-OLD GIRL WITH KMT2A::MLLT3 (MLL::AF9) FUSION
    Urabe, Keisuke
    Kayatani, Rishu
    Katayama, Daisuke
    Sugita, Yuko
    Takitani, Kimitaka
    Ashida, Akira
    PEDIATRIC BLOOD & CANCER, 2024, 71 : S40 - S40
  • [24] NUP98/HOXA13 FUSION GENE AND HIGH MSI2 GENE EXPRESSION IN BLASTIC PHASE CHRONIC MYELOID LEUKEMIA
    Di Giacomo, D.
    Pierini, V.
    Arcioni, F.
    Brunetti, L.
    Barba, G.
    Gorello, P.
    Gottardi, E.
    Mecucci, C.
    HAEMATOLOGICA, 2012, 97 : 67 - 68
  • [25] HETEROGENEOUS MECHANISMS AT THE BASIS OF 5′BCR/3′ABL FUSION GENE GENERATION IN CHRONIC MYELOID LEUKEMIA
    Albano, F.
    Anelli, L.
    Zagaria, A.
    Coccaro, N.
    Pannunzio, A.
    Rossi, A. Russo
    Vicari, L.
    Manodoro, F.
    Liso, V.
    Rocchi, M.
    Specchia, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 129 - 130
  • [26] Chronic myeloid leukemia with an e1a3 BCR-ABL fusion protein: Transformation to lymphoid blast crisis
    Martinez-Serra J.
    del Campo R.
    Gutierrez A.
    Antich J.L.
    Ginard M.
    Durán M.A.
    Bento L.
    Ros T.
    Amat J.C.
    Vidal C.
    Iglesias J.F.
    Orlinska I.
    Besalduch J.
    Biomarker Research, 2 (1)
  • [27] Clinical and cytogenetic complete remission (CR) with STI571 therapy in a patient with Philadelphia chromosome (Ph)-positive chronic myeloid leukemia (CML) in T-cell lymphoid blastic phase (BP).
    Lunin, SD
    Quackenbush, RC
    Talpaz, M
    Lin, H
    Guo, JQ
    Arlinghaus, RB
    Resta, D
    Kantarjian, H
    BLOOD, 2000, 96 (11) : 736A - 736A
  • [28] Unusual clinical course and acquisition of del(11)(q23) in second lymphatic blastic phase of a Ph-positive chronic myeloid leukemia
    Dierlamm, J
    Stefanova, M
    Michaux, L
    Lincke, E
    Leberecht, P
    Hossfeld, DK
    CANCER GENETICS AND CYTOGENETICS, 1999, 113 (01) : 85 - 89
  • [29] Overexpression of MEL1 as a novel fusion partner of AML1 in the blastic phase of chronic myeloid leukemia with the recurrent cryptic translocation t(1;21)(p36.3;q22)
    Hazourli, S
    Chagnon, P
    Fetni, R
    Busque, L
    Hebert, J
    BLOOD, 2005, 106 (11) : 163B - 163B
  • [30] Global Representation in Phase 2 and Phase 3 Clinical Trials for Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia
    Casey, Mycal
    Odhiambo, Lorriane
    Aggarwal, Nidhi
    Shoukier, Mahran
    Islam, Km
    Cortes, Jorge E.
    BLOOD, 2022, 140 : 5274 - 5275
12345